Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lederle International appears to have been the international pharmaceutical division or trade name associated with Lederle, a historical pharmaceuticals business within American Cyanamid and later Wyeth. Historical references describe it as sponsoring medical symposia and operating as part of a multinational prescription-drug business rather than as a standalone modern biotech company. The broader Lederle organization was known for marketed pharmaceutical and vaccine products, but specific current pipeline details for Lederle International as a distinct entity are not available. The Lederle business lineage passed through American Cyanamid, then Wyeth/American Home Products, and ultimately became part of Pfizer after Pfizer completed its acquisition of Wyeth in 2009. As a result, Lederle International should be treated primarily as a historical pharmaceutical business name rather than an active independent company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lederle International.